Yohann Loriot

Also affiliated with Inserm, Université Paris-Saclay, Institut Gustave Roussy

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors”.

Gut microbiome influences efficacy of PD-1–based immunotherapy against epithelial tumors

Science(2018)10.1126/science.aan3706

N/A

1.3DataRank · unranked

5316 citations

Emmanuelle Le Chatelier, Lisa Derosa, Connie P. M. Duong, Maryam Tidjani Alou, Romain Daillère +48 more

End Points for the Next-Generation Bladder-Sparing Perioperative Trials for Patients With Muscle-Invasive Bladder Cancer

Journal of Clinical Oncology(2025)10.1200/jco-25-01608

N/A

0DataRank · unranked

16 citations

Matthew D. Galsky, Nazlı Dizman, David H. Aggen, Neeraj Agarwal, Hikmat Al‐Ahmadie +39 more

Plain language summary of the THOR Cohort 1 study comparing treatment with erdafitinib or chemotherapy in advanced or metastatic urothelial cancer

Future Oncology(2025)10.1080/14796694.2025.2511589

N/A

0DataRank · unranked

0 citations

Spyros Triantos, Kris Deprince, Arlene O. Siefker‐Radtke, Yohann Loriot